Search for Clinical Trial Results

Sponsored By

Nut Hypersensitivity - 32 Studies Found

Status Study
Completed Study Name: A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy
Condition:
  • Peanut Hypersensitivity
  • Food Hypersensitivity
  • Drug: Peanut powder Delivered

Active, not recruiting Study Name: Peanut Oral Immunotherapy in Children
Condition: Peanut Hypersensitivity
Date: 2013-05-23
Interventions:
  • Biological: Peanut Oral Immunotherapy - Liquid Extract

Completed Study Name: Epicutaneous Immunotherapy in Peanut Allergy in Children
Condition: Peanut Allergy
Date: 2010-09-07
Interventions:
  • Biological: Epicutaneous Immunotherapy

Completed Study Name: Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization
Condition: Peanut Allergies in Children
Date: 2012-06-19
Interventions: Drug: Ketotifen titrated dose: 1 mg once a day, then 1 mg twice a day then 2 mg twice a day
Completed Study Name: PALISADE Follow-on Study (ARC004)
Condition: Peanut Allergy
Date: 2016-12-08
Interventions: Biological: AR101 AR101 powder provided in capsules & sachets
Active, not recruiting Study Name: Oral Peanut Immunotherapy
Condition: Peanut Allergy
Date: 2010-08-12
Interventions: Drug: Peanut flour OIT Patients will receive daily escalating dosages as determined in the modified rush
Enrolling by invitation Study Name: Identification of Anaphylactogenic Antibodies in Peanut Allergy
Condition: Peanut Allergy
Date: 2016-06-29
Interventions: Other: Observational study Blood sampling
Active, not recruiting Study Name: Safety Study of Viaskin Peanut to Treat Peanut Allergy
Condition: Peanut Allergy
Date: 2016-09-26
Interventions:
  • Biological: Viaskin Peanut 250 mcg
  • Biologi
Active, not recruiting Study Name: Treatment of Severe Peanut Allergy With Xolair (Omalizumab) and Oral Immunotherapy
Condition: Peanut Allergy
Date: 2013-11-28
Interventions: Drug: Omalizumab Omalizumab is the treatment during oral immunotherapy with peanuts as protection
Active, not recruiting Study Name: Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy
Condition: Peanut Allergy
Date: 2015-11-19
Interventions:
  • Biological: Viaskin Peanut 250mcg

<<< Previous | Next >>>